Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-SC013870-1
Host Cell : HEK293 Size : >1x106 frozen cells/vial
| Cat. No. | CSC-SC013870-1 |
| Description | This cell line is engineered to stably overexpress human SCN4A gene. |
| Target Gene | SCN4A |
| Gene Species | Homo sapiens (Human) |
| Host Cell | HEK293 |
| Host Cell Species | Homo sapiens (Human) |
| Applications |
1. Gene expression studies 2. Signaling pathway research 3. Drug screening and toxicology 4. Channelopathies research |
| Size | >1x106 frozen cells/vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Media Type | Cells were cultured in DMEM supplemented with 10% fetal bovine serum. |
| Growth Properties | Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Split at 80-90% confluence, approximately 1:3-1:6. |
| Freeze Medium | Complete medium supplemented with 10% (v/v) DMSO |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | SCN4A sodium channel, voltage-gated, type IV, alpha subunit [ Homo sapiens ] |
| Gene Symbol | SCN4A |
| Synonyms | HYPP; SkM1; HYKPP; NAC1A; HOKPP2; Nav1.4; Na(V)1.4 |
| Gene Description | sodium channel, voltage-gated, type IV, alpha subunit |
| GeneID | 6329 |
| Uni ProtID | P35499 |
| mRNA Refseq | NM_000334.4 |
| Protein Refseq | NP_000325.4 |
| Chromosome Location | 17q23.3 |
| Function | voltage-gated sodium channel activity; |
| Pathway | Axon guidance, organism-specific biosystem; Developmental Biology, organism-specific biosystem; Interaction between L1 and Ankyrins, organism-specific biosystem; L1CAM interactions, organism-specific biosystem; |
| MIM | 603967 |
The SCN4A gene encodes the alpha subunit of the voltage-gated sodium channel Nav1.4, a transmembrane protein complex responsible for the initiation and propagation of action potentials in skeletal muscle. Composed of a large pore-forming alpha subunit with 24 transmembrane domains along with regulatory beta subunits, Nav1.4 plays a central role in muscle excitation-contraction coupling. Mutations in SCN4A have been linked to a spectrum of neuromuscular disorders, including hyperkalemic periodic paralysis, paramyotonia congenita, potassium-aggravated myotonia, and congenital myasthenic syndrome, making it a well-established target for ion channel research and drug development. The Human SCN4A Stable Cell Line - HEK293 is a recombinant cell line generated by transfecting the human SCN4A gene into HEK293 cells, which are widely used for heterologous expression due to their low background of endogenous ion channels, ease of culture, and high transfection efficiency. These cells constitutively express functional Nav1.4 channels on the plasma membrane, providing a reliable and reproducible in vitro system for studying sodium channel properties in a controlled cellular environment.
This stable cell line serves as a versatile tool for a range of research applications. It is commonly used in electrophysiological assays, such as patch-clamp recordings, to characterize the biophysical properties of Nav1.4 channels, including activation, inactivation, and recovery kinetics, as well as to evaluate the functional effects of disease-associated mutations. The line is also well suited for high-throughput screening of small molecule modulators, including sodium channel blockers, activators, and use-dependent inhibitors. Additionally, researchers rely on this cell line for safety pharmacology assessments, particularly in evaluating off-target cardiotoxicity or neurotoxicity risks during early-stage drug discovery. The consistent expression of Nav1.4 in a mammalian cell background makes it a practical alternative to primary skeletal muscle cells, which are difficult to obtain and maintain in culture. Whether used for studying channel gating mechanisms, investigating genotype-phenotype correlations, or screening lead compounds, the Human SCN4A Stable Cell Line - HEK293 offers a robust and reproducible platform for both basic and translational research in the field of ion channel biology.
Sodium channel myotonia (SCM) and paramyotonia congenita (PMC) are rare non-dystrophic muscle disorders caused by gain-of-function mutations in the skeletal muscle voltage-gated sodium channel gene (SCN4A), leading to muscle hyperexcitability. Here, researchers conducted a comprehensive clinical and biophysical characterization of the rare variant NM_000334.4(SCN4A) c.4307T>C (p.Leu1436Pro; L1436P), which affects the skeletal muscle sodium channel Nav1.4, and compared its functional consequences with those of the wild-type (WT) channel and the established pathogenic variant p.Arg1448His (R1448H). Using whole-cell recording techniques, the researchers identified the biophysical defects associated with L1436P: the mutation significantly slowed the fast inactivation process of Nav currents at multiple voltage levels, although the magnitude of this effect was less pronounced than that observed with R1448H. The L1436P mutation also tended to cause a rightward shift in the steady-state inactivation curve, but this was observed only at low temperatures. In contrast, the R1448H mutation exhibited a leftward shift in the activation curve at both low and room temperatures, a phenomenon not seen with L1436P. Both mutants displayed slowed recovery from the fast-inactivated state, though this effect was limited to low-temperature conditions.
In this study, the biophysical characteristics of the mutant channels were compared to those of WT channels and R1448H, using whole-cell patch clamp recordings of hNav1.4 currents in stably transfected HEK293 cells (Figure 1). Recordings were performed at near physiological temperature (32°C), room temperature (22°C) and cold temperature (15°C). The results showed that the activation voltage of the L1436P mutant was identical to that of the WT channel; in contrast, the R1448H mutant exhibited a significant negative shift in activation voltage at low and room temperatures, a phenomenon not observed at 32°C.
Figure 1. Activation and fast inactivation of L1436P, R1448H and WT channels (A) Raw traces of Nav currents that were recorded at 22°C in WT hNav1.4- or mutant hNav1.4-expressing HEK293Tcells. (B) Normalized conductance (G/Gmax) versus voltage curves obtained for L1436P (n = 10); R1448H (n = 6), and WT channels (n = 6) using the equation G = I/(V-Vrev), with Vrev being +69 mV under our conditions. (Wang F C, et al., 2025)
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
The SCN4A stable cell line was straightforward to maintain and performed reliably in our functional assays. It provided a convenient cellular background for characterizing channel activity and evaluating test compounds.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.